Sebby Borriello Email & Phone Number

New York, NY, US

MIDAS Healthcare Solutions is poised to provide the first comprehensive solution to aid in the prevention of medication theft and abuse, also known as diversion, in healthcare institutions and homes.

New York, NY, US

MIDAS Healthcare Solutions is poised to provide the first comprehensive solution to aid in the prevention of medication theft and abuse, also known as diversion, in healthcare institutions and homes.

The mission is to identify novel therapeutics for life-threatening diseases that have no standard of care or lack effective therapy. Dedicated to treating diseases with significant unmet needs by expanding the promise of precision medicine.In 2019, we were the first-and-only global pharmaceutical company focused on the noncatalytic regulatory roles of.

Senior Executive with distinguished record of results in key leadership positions across the pharmaceutical and medical device industries. Providing guidance in developing strategy across the healthcare sector and refocusing pharmaceutical and medical device organizations for success. Strong track record of impact, high performance, and turnarounds across.

Pittsburgh, PA, US

https://www.businesswire.com/news/home/20220511005042/en/Carmell-Therapeutics-Announces-the-Appointment-of-Sebastian-%E2%80%9CSebby%E2%80%9D-Borriello-to-Chief-Business-OfficerIts an honor to join Carmell and it distinguished leadership team. Our Groundbreaking Plasma-based Bioactive Materials (PBMs) are Designed to Improve Patient Outcomes and Thereby.

• Recruited to evolve the company from a pure R&D/clinical organization to fully integrated pharmaceutical company with commercial capabilities
• Built commercial infrastructure and organization for successful market adoption of company’s future product launches which include sales, marketing, commercial operations, market access, and trade
• Led development and execution of commercialization strategy
• Launched XCOPRI® (cenobamate) for Focal Seizures in Adults in May 2020
• Successful XCOPRI® launch (through April 2021). NBRxs and TRxs have outpaced the previous 3 product launches for Focal Seizures in Adults. This is particularly noteworthy given the XCOPRI® product launch took place.
• Presented the XCOPRI® U.S. value proposition during the SK biopharmaceutical IPO deal roadshow in June 2020. IPO raised ~$880M USD and generated the most investor demand in the history of Korean Stock Exchange IPOs

Chapel Hill, North Carolina, US

• Crafted marketing materials and sales strategies for launch of Solithromycin
• Organized advisory and consultant meetings
• Built strategic relationships with key stakeholders in medical community
• Recruited market development personnel

• US VP Sales and Marketing (9/2012-9/2014)
• Oversaw over $240M in sales of medical products for the aesthetic market
• Managed a team of 150 sales and marketing employeesNational Sales Director (5/2011-8/2012)
• Led the launch of four new commercial products in 12 months, resulting in $20M in incremental revenue
• Prioritized drive of hospital sales, which surpassed private practice sales for first time in company history
• Collaborated with Ethicon to expand into new growth areas within plastic surgery channel

Piscataway, New Jersey, US

• Led company collaboration across the IDN, Government and GPO channels for 94 Medical Device, Pharmaceutical, and Consumer accounts
• Evolved business strategies of medical device sector with large IDNs
• Enhanced the account management competency model, resulting in a talent upgrade

• World Wide Director of Marketing BioPatch Products, J&J Wound Management (7/2008-12/2009)
• Oversaw regulatory approval for the sales and marketing of Biopatch for new markets in EMEA and AP
• Grew outside US revenue of BioPatch brand by 47%
• Assembled and trained sales and marketing teams in Middle East, Latin America, Canada and Australia Director Sales & Marketing, J&J Biosurgicals (1/2006-6/2008)
• Oversaw talent acquisition for key positions, including Region Sales Director, Group Product Director and Marketing Directors
• Grew business plan by 21% over previous year Director Sales & Marketing, J&J Advanced Wound Care (AWC) (3/2005-12/2005)

Jakarta, ID

• Held a variety of sales and business development roles over the course of 17 years, overseeing regional sales and marketing efforts
• Managed 48% increase in sales growth in both 2002 and 2003 for TOPAMAX brand, resulting in $804M total sales in 2003; Almost doubled CNS specialty sales force in 2003
• Lead for the American Academy of Neurology (AAN)
• Improved third party reimbursement from 30% to 65% in 7 months
• Led all 10 regions in LEVAQUIN sales for 2 years in a row
• Performed among top 3 regions for ULTRAM sales performance

Master'S Degree, Organizational Dynamics

Ba, Political Science/Public Administration

Education record